US FDA lifts clinical hold on Novavax's combo COVID-flu shot
2024年11月11日 · The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be...
U.S. FDA Removes Clinical Hold on Novavax's COVID-19 …
2024年10月16日 · Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the...
U.S. FDA Removes Clinical Hold on Novavax's COVID-19 …
GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food...
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
2024年11月12日 · Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its Covid-19 and influenza combination vaccine (CIC) and standalone influenza vaccines after a month-long clinical hold. The FDA initially halted the trials on 16 October after a patient in the Phase II trial (NCT05519839) of the ...
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine ...
2024年11月11日 · (RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza...
FDA lifts clinical hold on Novavax's combo COVID-flu shot
2024年11月11日 · The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after identifying a safety concern.
UPDATE: FDA Lifts Clinical Hold on Novavax’s COVID/Flu Vaccine ...
2024年11月11日 · Shares of Novavax fell 16% on Wednesday as the FDA placed a clinical hold on its investigational combo COVID-19/influenza and standalone influenza vaccines after a report of a serious adverse event in a trial participant.
US FDA pauses Novavax's trial of combo COVID-flu shot on …
2024年10月16日 · The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve...
U.S. FDA Removes Clinical Hold on Novavax's COVID-19 …
2024年11月11日 · Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the...
FDA removes clinical trial hold on Novavax COVID-flu combo and flu …
2024年11月12日 · Novavax yesterday announced that the US Food and Drug Administration (FDA) has released a clinical hold on its new drug application for its COVID-flu combination and standalone flu vaccines. In a statement, the company said the step paves the way for it to begin enrolling participants for a phase 3 trial. Asian Development Bank / Flickr cc